Among cell therapy companies, the pressure to manufacture innovation and optimization can incentivize them to seek third-party partners who possess technical, manufacturing, and regulatory expertise, such as cell therapy contract and development manufacturing organizations (CDMOs). Currently, there are an incredible 135 different CDMOs specializing in manufacturing and clinical trial support for cell and gene therapy developers.
Benefits of partnering with a cell therapy CDMO include scalability, speed to market, access to technical expertise without overhead costs, and cost efficiencies. [Read more…]